Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Convertible Debt (2018 - 2025)

Cosmos Health's Convertible Debt history spans 7 years, with the latest figure at $3.9 million for Q3 2025.

  • Quarterly results put Convertible Debt at $3.9 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $3.9 million (changed N/A YoY), and the annual figure for FY2023 was $100000.0, down 80.95%.
  • Convertible Debt for Q3 2025 was $3.9 million at Cosmos Health, up from $100000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $3.9 million in Q3 2025 to a low of $100000.0 in Q3 2022.
  • The 4-year median for Convertible Debt is $525000.0 (2022), against an average of $803668.4.
  • The sharpest move saw Convertible Debt plummeted 94.69% in 2021, then fell 17.97% in 2022.
  • Year by year, Convertible Debt stood at $640000.0 in 2021, then fell by 17.97% to $525000.0 in 2022, then crashed by 80.95% to $100000.0 in 2023, then soared by 3814.05% to $3.9 million in 2025.
  • According to Business Quant data, Convertible Debt over the past three periods came in at $3.9 million, $100000.0, and $100000.0 for Q3 2025, Q4 2023, and Q1 2023 respectively.